Deep neural networks identify signaling mechanisms of ErbB-family drug resistance from a continuous cell morphology space
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 34 (3) , 108657
Abstract
No abstract availableKeywords
Funding Information
- V. Kann Rasmussen Foundation (VKR 022758)
- Innovationsfonden (1311-00010B)
- Bundesministerium für Forschung, Technologie und Raumfahrt (031B0988)
- Lundbeck Foundation
This publication has 32 references indexed in Scilit:
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and CufflinksNature Protocols, 2012
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- Genetic Heterogeneity in Human DiseaseCell, 2010
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic applicationNature Reviews Drug Discovery, 2010
- TopHat: discovering splice junctions with RNA-SeqBioinformatics, 2009
- Quantitative Morphological Signatures Define Local Signaling Networks Regulating Cell MorphologyScience, 2007
- Frequent overexpression of aurora B kinase, a novel drug target, in non–small cell lung carcinoma patientsMolecular Cancer Therapeutics, 2006
- Reducing the Dimensionality of Data with Neural NetworksScience, 2006
- Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell GrowthCancer Research, 2004